Antigens protected functional red blood cells by the membrane grafting of compact hyperbranched polyglycerols

• Published in: Journal of visualized experiments no. 71
• Main Authors: Chapanian, Rafi, Constantinescu, Iren, Brooks, Donald E, Scott, Mark D, Kizhakkedathu, Jayachandran
• Format: Journal Article
• Language: English
• Published: United States MyJove Corporation 02.01.2013
• Subjects: Antigens, Surface - chemistry; Antigens, Surface - immunology; Biocompatible Materials - chemistry; Biocompatible Materials - pharmacology; Erythrocyte Membrane - chemistry; Erythrocyte Membrane - drug effects; Erythrocyte Membrane - immunology; Erythrocyte Transfusion - methods; Erythrocytes - chemistry; Erythrocytes - drug effects; Erythrocytes - immunology; Glycerol - blood; Glycerol - chemistry; Glycerol - pharmacology; Humans; Immunology; Polymers - chemistry; Polymers - pharmacology
• ISSN: 1940-087X; 1940-087X
• DOI: 10.3791/50075

Red blood cell (RBC) transfusion is vital for the treatment of a number of acute and chronic medical problems such as thalassemia major and sickle cell anemia. Due to the presence of multitude of antigens on the RBC surface (~308 known antigens), patients in the chronic blood transfusion therapy develop alloantibodies due to the miss match of minor antigens on transfused RBCs. Grafting of hydrophilic polymers such as polyethylene glycol (PEG) and hyperbranched polyglycerol (HPG) forms an exclusion layer on RBC membrane that prevents the interaction of antibodies with surface antigens without affecting the passage of small molecules such as oxygen, glucose, and ions. At present no method is available for the generation of universal red blood donor cells in part because of the daunting challenge presented by the presence of large number of antigens (protein and carbohydrate based) on the RBC surface and the development of such methods will significantly improve transfusion safety, and dramatically improve the availability and use of RBCs. In this report, the experiments that are used to develop antigen protected functional RBCs by the membrane grafting of HPG and their characterization are presented. HPGs are highly biocompatible compact polymers, and are expected to be located within the cell glycocalyx that surrounds the lipid membrane and mask RBC surface antigens.